Abhinav Talwar

Publication Activity (10 Years)

Years Active: 2022-2023
Publications (10 Years): 6

Top Topics

Postmenopausal Women

Neoadjuvant Chemotherapy

Health Insurance

Top Venues

Otolaryngology--head and neck surgery : official journal of American Academy of Otolaryngology-Head and Neck Surgery

JBJS case connector

The American surgeon

This page only lists publications with an associated author ORCID identifier.

Publications

Abhinav Talwar, Sooyoung Kim, Shun Yu, Sandeep Samant, Yesim Tozan, Babak Givi
Private Payer-Negotiated Rates for FDA-Approved Head and Neck Cancer Immunotherapy and Chemotherapy Agents. Otolaryngology--head and neck surgery : official journal of American Academy of Otolaryngology-Head and Neck Surgery (2023)
Abhinav Talwar, Ashir Bansal, Gabriel Knight, Juan-Carlos Caicedo, Ahsun Riaz, Riad Salem
Adverse Events of Surgical Drain Placement: An Analysis of the NSQIP Database. The American surgeon (2023)
Abhinav Talwar, Sooyoung Kim, Shun Yu, Sandeep Samant, Yesim Tozan, Babak Givi
Private Payer-Negotiated Rates for FDA-Approved Head and Neck Cancer Immunotherapy and Chemotherapy Agents. Otolaryngology--head and neck surgery : official journal of American Academy of Otolaryngology-Head and Neck Surgery (2023)
Abhinav Talwar, Alex J Gordon, Arnaud F Bewley, Tanya Fancy, William M Lydiatt, Donald T Weed, Michael G Moore, Babak Givi
Distribution of the head and neck surgical oncology workforce in the United States. Head & neck 44 (11) (2022)
Abhinav Talwar, Evan Patel, Moses Tam, Fang Zhou, Kenneth Hu, Michael Persky, Alec Vaezi, Adam Jacobson, Babak Givi
Patterns of Care and Outcomes of Carcinosarcoma of the Major Salivary Glands. Otolaryngology--head and neck surgery : official journal of American Academy of Otolaryngology-Head and Neck Surgery (2022)
Abhinav Talwar, Jennifer Bai, James R Wester, Samer Attar, Terrance D Peabody, Jason H Ko
Vascularized Medial Femoral Condyle Periosteal Flaps With Allograft Bone for Distal Radius Giant Cell Tumors: A Case Report. JBJS case connector 12 (3) (2022)